Top

Published in:

Open Access 01-11-2016 | Sepsis and ICU (JL Vincent, Section Editor)

Understanding Long-Term Outcomes Following Sepsis: Implications and Challenges

Authors: Manu Shankar-Hari, Gordon D. Rubenfeld

Published in: Current Infectious Disease Reports | Issue 11/2016

Abstract

Sepsis is life-threating organ dysfunction due to infection. Incidence of sepsis is increasing and the short-term mortality is improving, generating more sepsis survivors. These sepsis survivors suffer from additional morbidities such as higher risk of readmissions, cardiovascular disease, cognitive impairment and of death, for years following index sepsis episode. In the first year following index sepsis episode, approximately 60 % of sepsis survivors have at least one rehospitalisation episode, which is most often due to infection and one in six sepsis survivors die. Sepsis survivors also have a higher risk of cognitive impairment and cardiovascular disease contributing to the reduced life expectancy seen in this population, when assessed with life table comparisons. For optimal design of interventional trials to reduce these bad outcomes in sepsis survivors, in-depth understanding of major risk factors for these morbid events, their modifiability and a causal relationship to the pathobiology of sepsis is essential. This review highlights the recent advances, clinical and methodological challenges in our understanding of these morbid events in sepsis survivors.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10. doi:10.1001/jama.2016.0287.PubMedPubMedCentralCrossRef

Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock. JAMA. 2016;315(8):775. doi:10.1001/jama.2016.0289.PubMedPubMedCentralCrossRef

Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis - Current Estimates and Limitations. Am J Respir Crit Care Med. 2015. doi:10.1164/rccm.201504-0781OC.

Churpek MM, Zadravecz FJ, Winslow C, Howell M, Edelson DP. Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients. Am J Respir Crit Care Med. 2015. doi:10.1164/rccm.201502-0275OC.

Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med. 2014;42(3):625–31. doi:10.1097/CCM.0000000000000026.PubMedPubMedCentralCrossRef

Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308–16. doi:10.1001/jama.2014.2637.PubMedCrossRef

Prescott HC, Langa KM, Liu V, Escobar GJ, Iwashyna TJ. Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med. 2014;190(1):62–9. doi:10.1164/rccm.201403-0471OC.PubMedPubMedCentralCrossRef

Aalen OO, Valberg M, Grotmol T, Tretli S. Understanding variation in disease risk: the elusive concept of frailty. Int J Epidemiol. 2015;44(4):1408–21. doi:10.1093/ije/dyu192.PubMedCrossRef

Iwashyna TJ, Netzer G, Langa KM, Cigolle C. Spurious inferences about long-term outcomes: the case of severe sepsis and geriatric conditions. Am J Respir Crit Care Med. 2012;185(8):835–41. doi:10.1164/rccm.201109-1660OC.PubMedPubMedCentralCrossRef

10.

Prescott HC, Dickson RP, Rogers MA, Langa KM, Iwashyna TJ. Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med. 2015;192(5):581–8. doi:10.1164/rccm.201503-0483OC.PubMedPubMedCentralCrossRef

11.

Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29(7 Suppl):S109–16.PubMedCrossRef

12.

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.PubMedCrossRef

13.

Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med. 2006;34(10):2576–82. doi:10.1097/01.CCM.0000239114.50519.0E.PubMedPubMedCentralCrossRef

14.

Chapman SJ, Hill AV. Human genetic susceptibility to infectious disease. Nat Rev Genet. 2012;13(3):175–88. doi:10.1038/nrg3114.PubMed

15.

Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):1655–63. doi:10.1001/archinte.167.15.1655.PubMedPubMedCentralCrossRef

16.

Yende S, Iwashyna TJ, Angus DC. Interplay between sepsis and chronic health. Trends Mol Med. 2014;20(4):234–8. doi:10.1016/j.molmed.2014.02.005.PubMedPubMedCentralCrossRef

17.

Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–74. doi:10.1038/nri3552.PubMedPubMedCentralCrossRef

18.

Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016. doi:10.1016/s2213-2600(16)00046-1.

19.

Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2014;41(1):3–11. doi:10.1097/SHK.0000000000000052.PubMedPubMedCentralCrossRef

20.

Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med. 2013;187(5):509–17. doi:10.1164/rccm.201211-1983OC.PubMedPubMedCentralCrossRef

21.

Lunney JR, Lynn J, Hogan C. Profiles of older medicare decedents. J Am Geriatr Soc. 2002;50(6):1108–12. doi:10.1046/j.1532-5415.2002.50268.x.PubMedCrossRef

22.

Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–92. doi:10.1001/jama.289.18.2387.PubMedCrossRef

23.

Lone NI, Walsh TS. Impact of intensive care unit organ failures on mortality during the five years after a critical illness. Am J Respir Crit Care Med. 2012;186(7):640–7. doi:10.1164/rccm.201201-0059OC.PubMedCrossRef

24.

Yende S, D’Angelo G, Kellum JA, Weissfeld L, Fine J, Welch RD, et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med. 2008;177(11):1242–7. doi:10.1164/rccm.200712-1777OC.PubMedPubMedCentralCrossRef

25.••

Shankar-Hari M, Ambler M, Mahalingasivam V, Jones A, Rowan K, Rubenfeld G. Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies. Critical Care. 2016;20(1):101. This systematic review challenges the causal relationship between sepsis and long-term mortality. Highlights methodological issues in the literatures.PubMedPubMedCentralCrossRef

26.••

Yende S, Linde-Zwirble W, Mayr F, Weissfeld LA, Reis S, Angus DC. Risk of cardiovascular events in survivors of severe sepsis. Am J Respir Crit Care Med. 2014;189(9):1065–74. doi:10.1164/rccm.201307-1321OC. Landmark paper on cadiovascular events in sepsis survivors and value of control arms in determining attributable risk to sepsis.PubMedPubMedCentralCrossRef

27.

McConnell S, Stuart EA, Devaney B. The truncation-by-death problem: what to do in an experimental evaluation when the outcome is not always defined. Eval Rev. 2008;32(2):157–86. doi:10.1177/0193841X07309115.PubMedCrossRef

28.

Zhang JX, Iwashyna TJ, Christakis NA. The performance of different lookback periods and sources of information for charlson comorbidity adjustment in Medicare claims. Med Care. 1999;37(11):1128–39.PubMedCrossRef

29.

Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399–424. doi:10.1080/00273171.2011.568786.CrossRef

30.

Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550–60.PubMedCrossRef

31.

Hofler M. The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol. 2005;2:11. doi:10.1186/1742-7622-2-11.PubMedPubMedCentralCrossRef

32.•

Prescott HC, Osterholzer JJ, Langa KM, Angus DC, Iwashyna TJ. Late mortality after sepsis: propensity matched cohort study. BMJ. 2016;353. doi:10.1136/bmj.i2375. Highlights post-acute mortality in sepsis survivors using novel statistical methods.

33.•

Ou SM, Chu H, Chao PW, Lee YJ, Kuo SC, Chen TJ, et al. Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study. Am J Respir Crit Care Med. 2016;194(2):209–17. doi:10.1164/rccm.201510-2023OC. Highlights post acute mortality in sepsis survivors.PubMedCrossRef

34.

Funk MJ, Westreich D, Wiesen C, Sturmer T, Brookhart MA, Davidian M. Doubly robust estimation of causal effects. Am J Epidemiol. 2011;173(7):761–7. doi:10.1093/aje/kwq439.PubMedPubMedCentralCrossRef

35.

Linder A, Guh D, Boyd JH, Walley KR, Anis AH, Russell JA. Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med. 2014;42(10):2211–8. doi:10.1097/CCM.0000000000000503.PubMedCrossRef

36.

Prescott HC, Langa KM, Iwashyna TJ. Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions. JAMA. 2015;313(10):1055–7. doi:10.1001/jama.2015.1410.PubMedPubMedCentralCrossRef

37.

Jones TK, Fuchs BD, Small DS, Halpern SD, Hanish A, Umscheid CA, et al. Post-acute care use and hospital readmission after sepsis. Ann Am Thorac Soc. 2015;12(6):904–13. doi:10.1513/AnnalsATS.201411-504OC.PubMedPubMedCentralCrossRef

38.

Sun A, Netzer G, Small DS, Hanish A, Fuchs BD, Gaieski DF, et al. Association between index hospitalization and hospital readmission in sepsis survivors. Crit Care Med. 2016;44(3):478–87. doi:10.1097/CCM.0000000000001464.PubMedCrossRef

39.

Donnelly JP, Hohmann SF, Wang HE. Unplanned readmissions after hospitalization for severe sepsis at academic medical center-affiliated hospitals. Crit Care Med. 2015;43(9):1916–27. doi:10.1097/CCM.0000000000001147.PubMedPubMedCentralCrossRef

40.

Chang DW, Tseng CH, Shapiro MF. Rehospitalizations following sepsis: common and costly. Crit Care Med. 2015;43(10):2085–93. doi:10.1097/CCM.0000000000001159.PubMedPubMedCentralCrossRef

41.

Ortego A, Gaieski DF, Fuchs BD, Jones T, Halpern SD, Small DS, et al. Hospital-based acute care use in survivors of septic shock. Crit Care Med. 2015;43(4):729–37. doi:10.1097/ccm.0000000000000693.PubMedPubMedCentralCrossRef

42.

Goodwin AJ, Rice DA, Simpson KN, Ford DW. Frequency, cost, and risk factors of readmissions among severe sepsis survivors. Crit Care Med. 2015;43(4):738–46. doi:10.1097/CCM.0000000000000859.PubMedPubMedCentralCrossRef

43.

Zilberberg MD, Shorr AF, Micek ST, Kollef MH. Risk factors for 30-day readmission among patients with culture-positive severe sepsis and septic shock: a retrospective cohort study. J Hosp Med. 2015;10(10):678–85. doi:10.1002/jhm.2420.PubMedCrossRef

44.

Borzecki AM, Chen Q, Restuccia J, Mull HJ, Shwartz M, Gupta K et al. Do pneumonia readmissions flagged as potentially preventable by the 3M PPR software have more process of care problems? A cross-sectional observational study. BMJ Qual Saf. 2015. doi:10.1136/bmjqs-2014-003911.

45.••

Krumholz HM, Lin Z, Keenan PS, Chen J, Ross JS, Drye EE, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2013;309(6):587–93. doi:10.1001/jama.2013.333. Landmark paper on readmissions literature.PubMedPubMedCentralCrossRef

46.

Wang T, Derhovanessian A, De Cruz S, Belperio JA, Deng JC, Hoo GS. Subsequent infections in survivors of sepsis: epidemiology and outcomes. J Intensive Care Med. 2014;29(2):87–95. doi:10.1177/0885066612467162.PubMedCrossRef

47.

Ehlenbach WJ, Hough CL, Crane PK, Haneuse SJ, Carson SS, Curtis JR, et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA. 2010;303(8):763–70. doi:10.1001/jama.2010.167.PubMedPubMedCentralCrossRef

48.

Mathews SB, Arnold SE, Epperson CN. Hospitalization and cognitive decline: can the nature of the relationship be deciphered? Am J Geriatr Psychiatry. 2014;22(5):465–80. doi:10.1016/j.jagp.2012.08.012.PubMedCrossRef

49.

Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94. doi:10.1001/jama.2010.1553.PubMedPubMedCentralCrossRef

50.••

Shah FA, Pike F, Alvarez K, Angus D, Newman AB, Lopez O, et al. Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med. 2013;188(5):586–92. doi:10.1164/rccm.201212-2154OC. Important paper that addresses challenges with pre-illness cognitive decline and pneumonia.PubMedPubMedCentralCrossRef

51.

Davydow DS, Hough CL, Zivin K, Langa KM, Katon WJ. Depression and risk of hospitalization for pneumonia in a cohort study of older Americans. J Psychosom Res. 2014;77(6):528–34. doi:10.1016/j.jpsychores.2014.08.002.PubMedPubMedCentralCrossRef

52.

Davydow DS, Hough CL, Langa KM, Iwashyna TJ. Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans. Am J Geriatr Psychiatry. 2013;21(9):887-97. doi:10.1016/j.jagp.2013.01.017. 10.1097/JGP.0b013e31825c0aed.

53.•

Klein Klouwenberg PM, Zaal IJ, Spitoni C, Ong DS, van der Kooi AW, Bonten MJ, et al. The attributable mortality of delirium in critically ill patients: prospective cohort study. BMJ. 2014;349:g6652. doi:10.1136/bmj.g6652. Conceptual paper exploring acute delerium and attributable mortality.PubMedPubMedCentralCrossRef

54.

Wolters AE, van Dijk D, Pasma W, Cremer OL, Looije MF, de Lange DW, et al. Long-term outcome of delirium during intensive care unit stay in survivors of critical illness: a prospective cohort study. Crit Care. 2014;18(3):R125. doi:10.1186/cc13929.PubMedPubMedCentralCrossRef

55.

Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513–20. doi:10.1097/CCM.0b013e3181e47be1.PubMedPubMedCentralCrossRef

56.

Popp J. Delirium and cognitive decline: more than a coincidence. Curr Opin Neurol. 2013;26(6):634–9. doi:10.1097/wco.0000000000000030.PubMedCrossRef

57.

Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium. J Intensive Care. 2016;4(1):1–7. doi:10.1186/s40560-016-0145-4.CrossRef

58.

Jones RN, Manly J, Glymour MM, Rentz DM, Jefferson AL, Stern Y. Conceptual and measurement challenges in research on cognitive reserve. J Int Neuropsychol Soc. 2011;17(4):593–601. doi:10.1017/s1355617710001748.PubMedPubMedCentralCrossRef

59.

Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang CC, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313(3):264–74. doi:10.1001/jama.2014.18229.PubMedPubMedCentralCrossRef

60.

Dalager-Pedersen M, Sogaard M, Schonheyder HC, Nielsen H, Thomsen RW. Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation. 2014;129(13):1387–96. doi:10.1161/circulationaha.113.006699.PubMedCrossRef

61.

Mejer N, Gotland N, Uhre ML, Westh H, Schonheyder HC, Petersen A, et al. Increased risk of arterial thromboembolic events after Staphylococcus aureus bacteremia: a matched cohort study. J Infect. 2015;71(2):167–78. doi:10.1016/j.jinf.2015.03.010.PubMedCrossRef

62.

Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010;38(5):1276–83. doi:10.1097/CCM.0b013e3181d8cc1d.PubMedCrossRef

63.

Nesseler N, Defontaine A, Launey Y, Morcet J, Malledant Y, Seguin P. Long-term mortality and quality of life after septic shock: a follow-up observational study. Intensive Care Med. 2013;39(5):881–8. doi:10.1007/s00134-013-2815-1.PubMedCrossRef

64.

Uthbertson BH, Elders A, Hall S, Taylor J, MacLennan G, Mackirdy F, et al. Mortality and quality of life in the five years after severe sepsis. Crit Care. 2013;17(2):R70. doi:10.1186/cc12616.CrossRef

65.

Yende S, Austin S, Rhodes A, Finfer S, Opal S, Thompson T et al. Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials. Crit Care Med. 2016. doi:10.1097/CCM.0000000000001658.

66.

Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA. Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life. Crit Care Med. 2000;28(11):3599–605.PubMedCrossRef

67.

Granja C, Dias C, Costa-Pereira A, Sarmento A. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit Care. 2004;8(2):R91–8. doi:10.1186/cc2818.PubMedPubMedCentralCrossRef

68.

Orwelius L, Lobo C, Teixeira Pinto A, Carneiro A, Costa-Pereira A, Granja C. Sepsis patients do not differ in health-related quality of life compared with other ICU patients. Acta Anaesthesiol Scand. 2013;57(9):1201–5. doi:10.1111/aas.12164.PubMedCrossRef

69.

Feemster LC, Cooke CR, Rubenfeld GD, Hough CL, Ehlenbach WJ, Au DH et al. The Influence of Hospitalization or ICU Admission on Declines in Health-Related Quality of Life. Ann Am Thorac Soc. 2014. doi:10.1513/AnnalsATS.201404-172OC.

70.

Esper AM, Martin GS. The impact of comorbid [corrected] conditions on critical illness. Crit Care Med. 2011;39(12):2728–35. doi:10.1097/CCM.0b013e318236f27e.PubMedCrossRef

71.

Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–217. doi:10.1016/j.cell.2013.05.039.PubMedPubMedCentralCrossRef

72.

Weiterer S, Uhle F, Lichtenstern C, Siegler BH, Bhuju S, Jarek M, et al. Sepsis induces specific changes in histone modification patterns in human monocytes. PLoS One. 2015;10(3):e0121748. doi:10.1371/journal.pone.0121748.PubMedPubMedCentralCrossRef

73.

Bomsztyk K, Mar D, An D, Sharifian R, Mikula M, Gharib SA, et al. Experimental acute lung injury induces multi-organ epigenetic modifications in key angiogenic genes implicated in sepsis-associated endothelial dysfunction. Crit Care. 2015;19:225. doi:10.1186/s13054-015-0943-4.PubMedPubMedCentralCrossRef

74.

Bataille A, Galichon P, Ziliotis M-J, Sadia I, Hertig A. Epigenetic changes during sepsis: on your marks! Crit Care. 2015;19:358. doi:10.1186/s13054-015-1068-5.PubMedPubMedCentralCrossRef

75.

Venet F, Lukaszewicz AC, Payen D, Hotchkiss R, Monneret G. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol. 2013;25(4):477–83. doi:10.1016/j.coi.2013.05.006.PubMedPubMedCentralCrossRef

76.

Singer BH, Newstead MW, Zeng X, Cooke CL, Thompson RC, Singer K, et al. Cecal ligation and puncture results in long-term central nervous system myeloid inflammation. PLoS One. 2016;11(2):e0149136. doi:10.1371/journal.pone.0149136.PubMedPubMedCentralCrossRef

77.

Chavan SS, Huerta PT, Robbiati S, Valdes-Ferrer SI, Ochani M, Dancho M, et al. HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med. 2012;18:930–7. doi:10.2119/molmed.2012.00195.PubMedPubMedCentral

78.

Dal-Pizzol F, Pasquali M, Quevedo J, Gelain DP, Moreira JC. Is there a role for high mobility group box 1 and the receptor for advanced glycation end products in the genesis of long-term cognitive impairment in sepsis survivors? Mol Med. 2012;18:1357-8; author reply 9. doi:10.2119/molmed.2012.00317.

79.

Kaynar A, Yende S, Zhu L, Frederick D, Chambers R, Burton C, et al. Effects of intra-abdominal sepsis on atherosclerosis in mice. Crit Care. 2014;18(5):469.PubMedPubMedCentralCrossRef

80.

Sweeney TE, Shidham A, Wong HR, Khatri P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med. 2015;7(287):287ra71. doi:10.1126/scitranslmed.aaa5993.

81.

Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581–90. doi:10.1084/jem.20111354.PubMedPubMedCentralCrossRef

82.

van Vught LA, Klein Klouwenberg PM, Spitoni C, Scicluna BP, Wiewel MA, Horn J, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315(14):1469–79. doi:10.1001/jama.2016.2691.PubMedCrossRef

83.

Arens C, Bajwa SA, Koch C, Siegler BH, Schneck E, Hecker A, et al. Sepsis-induced long-term immune paralysis—results of a descriptive, explorative study. Crit Care. 2016;20(1):93. doi:10.1186/s13054-016-1233-5.PubMedPubMedCentralCrossRef

84.

Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594–605. doi:10.1001/jama.2011.1829.PubMedPubMedCentralCrossRef

85.

Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821.PubMedPubMedCentralCrossRef

86.

Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–8. doi:10.1126/science.1110591.PubMedPubMedCentralCrossRef

87.

Pham TA, Lawley TD. Emerging insights on intestinal dysbiosis during bacterial infections. Curr Opin Microbiol. 2014;17:67–74. doi:10.1016/j.mib.2013.12.002.PubMedPubMedCentralCrossRef

88.

Francino MP. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front Microbiol. 2015;6:1543. doi:10.3389/fmicb.2015.01543.PubMed

89.

Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B, Kade M et al. Membership and Behavior of Ultra-Low-Diversity Pathogen Communities Present in the Gut of Humans during Prolonged Critical Illness. mBio. 2014;5(5). doi:10.1128/mBio.01361-14.

Title: Understanding Long-Term Outcomes Following Sepsis: Implications and Challenges
Authors: Manu Shankar-Hari
Gordon D. Rubenfeld
Publication date: 01-11-2016
Publisher: Springer US
Published in: Current Infectious Disease Reports / Issue 11/2016
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-016-0544-7

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2016

Ocular Syphilis: a Clinical Review

Human Rabies: a 2016 Update

Central Nervous System Device Infections

Laboratory Diagnosis of Central Nervous System Infection

Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage